SOLID STATE CHEMICALS LTD. v. ASHLAND LLC

CourtDistrict Court, W.D. Pennsylvania
DecidedMarch 24, 2022
Docket2:19-cv-01044
StatusUnknown

This text of SOLID STATE CHEMICALS LTD. v. ASHLAND LLC (SOLID STATE CHEMICALS LTD. v. ASHLAND LLC) is published on Counsel Stack Legal Research, covering District Court, W.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
SOLID STATE CHEMICALS LTD. v. ASHLAND LLC, (W.D. Pa. 2022).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA PITTSBURGH SOLID STATE CHEMICALS LTD., AND; ) AND SOLID STATE CHEMICALS INC., ) ) 2:19-CV-01044-MJH Plaintiffs, ) ) vs. ) ) ) ASHLAND LLC, )

Defendant,

OPINION Plaintiffs, Solid State Chemicals LTD and Solid State Chemicals Inc., bring the within action against Defendant, Ashland, LLC, arising out of an alleged breach of a Manufacturing Services Agreement (MSA). (ECF No. 22). Ashland asserted a counterclaim on the same MSA. (ECF No. 23). Both Ashland and Solid State have moved for summary judgment on their respective claims and counterclaims. (ECF Nos. 54 and 57). The matter is now ripe for consideration. After consideration of Ashland and Solid State’s Motions for Summary Judgment (ECF Nos. 54 and 57), their respective briefs (ECF Nos. 55, 61, 69, 74, 82, and 84), Concise Statements of Material Fact and Appendices (ECF Nos. 56, 58-60, 65-66, 70-72, 75-76, 79-80, 85-88), the relevant pleadings, and for the following reasons, each of Ashland and Solid State’s Motions for Summary Judgment will be granted in part and denied in part. I. Background This dispute arises out of an MSA contract between Solid State and Ashland, which had an effective date of November 1, 2017, wherein Solid State agreed to supply raw materials and Ashland agreed to manufacture them into solid maleic anhydride. (ECF No. 85 at ¶ 21). Maleic anhydride, a common chemical intermediary, is a dangerous chemical and can be harmful to humans. Id. at ¶ 9. As such, it is subject to strict OSHA limits to protect workers from exposure. Id. at ¶ 10. The relevant OSHA standards have not been updated since the 1970s, and some companies rely upon other industry standards, such as the American Conference of

Governmental Industrial Hygienists (“ACGIH”) Threshold Limit Value (“TLV”). Id. at ¶ 11. For maleic anhydride, the current ACGIH TLV-TWA [time weighted average] of 0.01 mg/m3 (0.0025 ppm) was adopted in 2011. Id. at ¶ 12. The existing OSHA Personal Exposure Limit (PEL) of 1 mg/m3 (0.25 ppm) is 100 times less stringent than the AGCIH TLV. Id. On September 30, 2016, Ashland issued its latest policy standard for its operational Industrial Hygiene and Occupational Health Standard (“Ashland IH Policy”). Id. at ¶ 13. Said Policy requires that the lowest available Occupational Exposure Limit (“OEL”) for exposure assessments shall be established according to a listed hierarchy of OELs, including the ACGIH TLV. Id. Thus, since 2016, Ashland’s relevant IH Policy for exposure limits for maleic anhydride has been 0.01 mg/m3 (0.0025 ppm).

In early 2017, Jason Perry, president of Solid State, met with Ashland personnel to discuss the possibility of operating a pastillator line to produce solid maleic anhydride pastilles at Ashland’s facility in Neville Island, PA. Id. at ¶ 20. In anticipation of such business venture, in June 2017, Ashland’s Neville Island plant manager, John Greer, plant engineer, Al Lang, and environmental health and safety and industrial hygiene experts began appropriate hazard assessments and assembled information on what was needed to obtain the necessary permits. Id. at ¶ 22. During this process, Kara Long, Ashland’s environmental health and safety specialist, noted, “safety/IH concerns over this project due to the low OEL of maleic.” Id. Kristi Hames, Neville Island’s industrial hygienist, raised this same concern in regard to the pastillator line, commenting that “[w]e can’t rely on respirators alone to reduce exposures.” Id. On July 19, 2017, Jason Perry attended a meeting at Neville Island to discuss the pastillator process design and “all possible safety aspects of the process.” Id. at ¶ 23. Ashland’s Design Engineering Group reviewed the plans for building upgrades to install and connect the pastillator at Ashland’s

Neville Island facility. Id. at ¶ 24. Between August and October 2017, Ashland and Solid State negotiated various provisions of the MSA. Id. at ¶ 25. The MSA was executed in late October 2017 and became effective on November 1, 2017. Id. at ¶ 26. Under the MSA, Ashland was to manufacture solid maleic anhydride exclusively for Solid State at Ashland’s Neville Island facility “as specified in purchase orders submitted by” Solid State. Id. at ¶ 27. The purchase orders were to identify the quantity, date of delivery, and price. Id. Upon receipt of a purchase order, Ashland was to “acknowledge and confirm” the order and expected delivery dates. Id. Notwithstanding said MSA provisions, Solid State never submitted any such purchase orders. Id. at ¶ 31. Under the MSA, Solid State was to provide the necessary equipment, raw materials, and

product specifications, and Ashland was to ensure the Neville Island location had all necessary permits and approvals to manufacture and store solid maleic anhydride pastilles and to ensure that operation of the location was “compliant with all applicable laws.” Id. at ¶ 28. Because Ashland had not manufactured solid maleic anhydride for years, and because it had never made maleic anhydride pastilles using a pastillator, the MSA provided that Ashland’s obligation to run the line was expressly contingent on the line meeting all of Ashland’s legal and internal health and safety standards. Id. at ¶ 29. Section 2.9 of the MSA provides: 2.9. [Ashland] shall ensure that the Manufacturing Location has and maintains during the Term all permits and approvals necessary to manufacture and store the Products and the Raw Materials used to produce the Products and that the operation of the Manufacturing Location is compliant with all applicable laws. In no event will [Ashland] be required to perform any of its obligations under this Agreement in; (i) an unsafe or imprudent manner; (ii) contravention of [Ashland]’s environmental, health and safety standards; or (iii) violation of applicable laws.

(ECF No. 22-2 at pp. 3-5). The MSA also required: 2.10 As part of [Ashland] agreeing to manufacture the Products: (i) [Ashland] may be required to make additional capital investment to meet production needs, and (ii) [Solid State] will provide Equipment to [Ashland] for the manufacture of the Products, which shall be subject to the Bailment Agreement attached hereto as Schedule 4. In the event that additional significant capital investments or equipment are required to meet production demands, the Parties will agree on an appropriate cost amortization or bailment agreement to be executed by the Parties and incorporated to this Agreement by reference.

Id. In late November and early December 2017, Solid State’s pastillation equipment was delivered to Neville Island and installation efforts began. (ECF No. 85 at at ¶ 33). Ashland hired TRC Environmental Corporation (“TRC”), an environmental engineering firm. Id. at ¶ 34. On December 12, 2017, TRC conducted an onsite review of the areas where the pastillator line was to be located, the process equipment and associated ventilation systems, and the available design information in order to evaluate the proposed pastillation process and the objective to keep employee exposures below the ACGIH TLV standard. Id. On December 13, 2017, David Miller of Ashland’s Industrial Hygiene department emailed Ashland’s plant management and corporate personnel recommending against installing the pastillator because of toxic exposure concerns. Id. at ¶ 35. Mr. Miller noted that, requiring Personal Protective Equipment (PPE) as the primary source of protection for workers, would not be a viable option. Id. Ashland issued final approval for expenditures totaling $900,000 related to the pastillator project during January 2018. Id. at ¶ 36. In early 2018, installation of the pastillator line was completed. Id. at ¶ 37. Initial startup runs on the line occurred during June 2018. Id. at ¶ 40.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Howe v. Bank of New York Mellon
783 F. Supp. 2d 466 (S.D. New York, 2011)
Fcof Ub Securities LLC v. Morequity, Inc.
663 F. Supp. 2d 224 (S.D. New York, 2009)
Blunt v. Lower Merion School District
767 F.3d 247 (Third Circuit, 2014)
Michelle Moody v. Atlantic City Board of Educati
870 F.3d 206 (Third Circuit, 2017)
805 Third Ave. Co. v. M.W. Realty Associates
448 N.E.2d 445 (New York Court of Appeals, 1983)
Chase v. J.H. Electric of New York, Inc.
69 A.D.3d 802 (Appellate Division of the Supreme Court of New York, 2010)
Palmetto Partners, L.P. v. AJW Qualified Partners, LLC
83 A.D.3d 804 (Appellate Division of the Supreme Court of New York, 2011)
Gassman v. Rothlein
275 A.D.2d 731 (Appellate Division of the Supreme Court of New York, 2000)

Cite This Page — Counsel Stack

Bluebook (online)
SOLID STATE CHEMICALS LTD. v. ASHLAND LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/solid-state-chemicals-ltd-v-ashland-llc-pawd-2022.